3 Products
Bi-specific single-domain antibodies represent a groundbreaking advancement in the field of immunotherapy and targeted drug delivery. These innovative…
Select optionssdAb anti-CD62L is an in-house developed single-domain antibody (sdAb) binding the human lymphocyte marker CD62L (L-selectin) with high…
Select optionsThis anti-Sars-CoV-2 Spike protein S1 nanobody was developed by the team of Alejandro Rojas-Fernandez at the Institute of…
Select options